Abstracts

Maximizing Detection and Improving Outcomes of Cryptococcosis in Rural Tanzania

The WHO recommends pre-antiretroviral treatment (ART) CD4-targeted cryptococcal antigen (CRAG) screening in sub-Saharan Africa. Implementing this strategy only in outpatient settings may underestimate the true CRAG prevalence and decrease its impact. In October 2013, lab-reflex CRAG screening was implemented at the St. Francis Referral Hospital, Ifakara, Tanzania for all HIV+ hospitalized patients and outpatients with…

Evaluation of Provider-Initiated Cryptococcal Antigen Screening, South Africa

Cryptococcal antigen (CrAg) screening can identify persons at risk for disseminated cryptococcal disease (DCD); pre-emptive treatment can prevent disease progression. In August 2012, the Western Cape Province (WC) implemented provider-initiated CrAg screening among antiretroviral therapy (ART)-naïve patients with CD4 count <100 cells/µl followed by fluconazole treatment for asymptomatic CrAg-positive patients. We evaluated the implementation and…

48-Week Outcomes of African Children Starting ART at CD4>500 With Streamlined Care

With global guidelines shifting to universal antiretroviral therapy (ART) for HIV+ children, strategies are needed to scale-up ART efficiently while ensuring good clinical outcomes.  Data on children initiating ART at high CD4 counts are particularly limited. We evaluated retention in care, viral suppression, and safety in asymptomatic HIV+ children starting ART at CD4> 500 cells/μl…

Immunologic Discrimination of Cryptococcal IRIS From Culture-Positive Relapse

Immune Reconstitution Inflammatory Syndrome (IRIS) may complicate antiretroviral therapy (ART).  Whereas ART promotes HIV viral suppression and CD4+ T cell increases on a population level, the utility of these measurements as objective diagnostic criteria for IRIS remains unclear for an individual. We determined whether CD4 and plasma HIV RNA measurements are diagnostically useful to help…

Family Clinic Day RCT in Uganda: Child Antiretroviral Therapy Retention and Adherence

Uganda recently adopted a test-and-treat policy for HIV patients 15 years or younger. But despite increased eligibility, low retention rates among pediatric and adolescent antiretroviral therapy (ART) initiates could severely limit the impact of this new policy. This evaluation tested the impact of the Family Clinic Day (FCD) program, a facility based family-centered appointment scheduling…

Neurocognitive Function in HIV-Infected Persons With Cryptococcal Antigenemia

HIV-infected persons with detectable cryptococcal antigen (CRAG) in blood have increased mortality compared with HIV-infected persons who are CRAG-negative. This study examined neurocognitive function among persons with asymptomatic cryptococcal antigenemia. Participants from three prospective HIV cohorts underwent neurocognitive testing at time of antiretroviral therapy (ART) initiation. Cohorts included persons with cryptococcal meningitis (n=90), asymptomatic CRAG+…